Use of beta-1,3-glucan-specific antibody to study the cyst wall of Pneumocystis carinii and effects of pneumocandin B0 analog L-733,560.

A new class of promising antipneumocystis agents, cyclic lipopeptide pneumocandin analogs, has been shown to effectively prevent Pneumocystis carinii cyst development in murine models. These compounds are believed to inhibit the biosynthesis of beta-1,3-glucan, a major constituent of the cell walls...

Descrizione completa

Dettagli Bibliografici

Pubblicato in:	Antimicrob Agents Chemother
Autori principali:	Nollstadt, K H, Powles, M A, Fujioka, H, Aikawa, M, Schmatz, D M
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	American Society for Microbiology (ASM) 1994
Soggetti:	Research Article
Accesso online:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC284727/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/7840554/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.38.10.2258
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!